Glenmark Pharmaceuticals has announced the appointment of Kamlesh Gupta as Business Head, a move aimed at strengthening the company’s commercial strategy and accelerating its sales operations in a competitive pharmaceutical market.
Gupta brings more than 26 years of experience in the pharmaceutical industry, with deep expertise in sales leadership, business development, and managing large field teams across multiple therapeutic segments. His appointment is expected to bolster the company’s commercial capabilities and drive growth across key product portfolios.
Prior to joining Glenmark, Gupta held a leadership role at Mankind Pharma, where he served as Deputy Divisional Sales Manager. In that position, he played a significant role in overseeing sales operations, guiding field teams, and supporting the company’s efforts to expand its market presence across various therapeutic categories.
An MBA by qualification, Gupta has built a career centered on pharmaceutical sales management and commercial leadership. His extensive industry exposure has enabled him to lead high-performing teams and contribute to business growth initiatives across the sector.
Headquartered in Mumbai, Glenmark Pharmaceuticals develops, manufactures, and markets branded, generic, and specialty medicines for markets in India and globally. With Gupta’s appointment, the company is expected to further strengthen its commercial strategy and expand its footprint in the evolving pharmaceutical landscape.